ArticleEuropean journal of neurology2026

MIDAS and HIT-6 Questionnaires Versus Headache Diaries for Monitoring Treatment Response to Erenumab in Migraine: A REFORM Study.

Janu Thuraiaiyah et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.